Physician profile
Daniel J Pero
NPI 1891918215
$1,886.89
in general payments reported to CMS, 2019-2025
15 companies · $24.98 in 2025
The $24.98 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,411 · 2020: $23.43 · 2021: $30.17 · 2022: $287 · 2023: $111 · 2025: $24.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,073.08 | 2019 | |
| Amniox Medical, INC. | $279.69 | 2019 | |
| Bard Peripheral Vascular, INC. | $130.66 | 2022-2023 | Venclose Maven Catheter |
| Embody, INC. | $70.46 | 2022 | |
| Smith+Nephew, INC. | $69.80 | 2019-2021 | |
| Organogenesis INC. | $43.63 | 2022 | |
| Orthofix Medical, INC. | $42.83 | 2019-2022 | |
| Cashflow Solutions, LLC | $38.87 | 2022-2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Nevro Corp. | $29.81 | 2022 | |
| Djo, LLC | $24.98 | 2025 | Cmf |
| Acera Surgical, INC. | $24.73 | 2022 | |
| Abbott Laboratories | $20.07 | 2023 | Eterna |
| Treace Medical Concepts, INC. | $14.20 | 2022 | |
| Triad Life Sciences INC. | $12.47 | 2022 | |
| Bioventus LLC | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.